Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Highlights

Highlights January 15, 2019 Volume 321, Number 2 In This Issue of JAMA Pages 115-216 Research Opinion Viewpoint Fecal Microbiota Transplantation for Ulcerative Colitis 156 139 Rethinking How Antibiotics Are Preserving the viability of oxygen-sensitive bacteria may enhance the clinical eff ect of fe- Prescribed: Incorporating the 4 cal microbiota transplantation (FMT) for patients with ulcerative colitis. Costello and col- Moments of Antibiotic Decision leagues randomized 73 adults with mild to moderately active ulcerative colitis and found Making Into Clinical Practice PD Tamma, MA Miller, and SE Cosgrove that treatment with anaerobically prepared donor FMT compared with autologous FMT 141 Physicians’ Voices on Gun resulted in a higher likelihood of remission at 8 weeks. In an Editorial, Kelly and Anan- Violence and Other Important thakrishnan suggest that manipulation of the microbiome may be most eff ective when Public Health Issues used in combination with agents that target immune dysregulation. S Galea Editorial 151 143 Free Medical School Tuition: Summary Video and Visual Abstract jama.com Will It Accomplish Its Goals? B Thomas Stem Cell Transplantation for Multiple Sclerosis 165 145 Challenges of Non–Intention- Many patients with relapsing-remitting to-Treat Analyses Time to disease progression DL DeMets and T Cook multiple sclerosis have http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Highlights

JAMA , Volume 321 (2) – Jan 15, 2019

Loading next page...
 
/lp/american-medical-association/highlights-RNCvz0h5tj
Publisher
American Medical Association
Copyright
Copyright 2019 American Medical Association. All Rights Reserved.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2018.15146
Publisher site
See Article on Publisher Site

Abstract

January 15, 2019 Volume 321, Number 2 In This Issue of JAMA Pages 115-216 Research Opinion Viewpoint Fecal Microbiota Transplantation for Ulcerative Colitis 156 139 Rethinking How Antibiotics Are Preserving the viability of oxygen-sensitive bacteria may enhance the clinical eff ect of fe- Prescribed: Incorporating the 4 cal microbiota transplantation (FMT) for patients with ulcerative colitis. Costello and col- Moments of Antibiotic Decision leagues randomized 73 adults with mild to moderately active ulcerative colitis and found Making Into Clinical Practice PD Tamma, MA Miller, and SE Cosgrove that treatment with anaerobically prepared donor FMT compared with autologous FMT 141 Physicians’ Voices on Gun resulted in a higher likelihood of remission at 8 weeks. In an Editorial, Kelly and Anan- Violence and Other Important thakrishnan suggest that manipulation of the microbiome may be most eff ective when Public Health Issues used in combination with agents that target immune dysregulation. S Galea Editorial 151 143 Free Medical School Tuition: Summary Video and Visual Abstract jama.com Will It Accomplish Its Goals? B Thomas Stem Cell Transplantation for Multiple Sclerosis 165 145 Challenges of Non–Intention- Many patients with relapsing-remitting to-Treat Analyses Time to disease progression DL DeMets and T Cook multiple sclerosis have

Journal

JAMAAmerican Medical Association

Published: Jan 15, 2019

There are no references for this article.